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Uridylation occurs pervasively on mRNAs, yet its
mechanism and significance remain unknown. By
applying TAIL-seq, we identify TUT4 and TUT7
(TUT4/7), also known as ZCCHC11 and ZCCHC6,
respectively, as mRNA uridylation enzymes. Uridyla-
tion readily occurs on deadenylated mRNAs in cells.
Consistently, purified TUT4/7 selectively recognize
and uridylate RNAs with short A-tails (less than
25 nt) in vitro. PABPC1 antagonizes uridylation of
polyadenylated mRNAs, contributing to the speci-
ficity for short A-tails. In cells depleted of TUT4/7,
the vast majority of mRNAs lose the oligo-U-tails,
and their half-lives are extended. Suppression of
mRNA decay factors leads to the accumulation of
oligo-uridylated mRNAs. In line with this, microRNA
induces uridylation of its targets, and TUT4/7 are
required for enhanced decay of microRNA targets.
Our study explains the mechanism underlying
selective uridylation of deadenylated mRNAs and
demonstrates a fundamental role of oligo-U-tail as
a molecular mark for global mRNA decay.
INTRODUCTION
RNA tailing (nontemplated nucleotide addition to the 30 end of
RNA) is one of the most frequent types of RNA modification,
with a deep evolutionary root and diverse molecular functions.
In bacteria, adenylation of mRNA triggers RNA degradation
whereas polyadenylation in eukaryotes increases the stability
and translatability of mRNA (Dreyfus and Re´gnier, 2002). Tailing
is catalyzed by a group of template-independent ribonucleotidyl
transferases that contain DNA polymerase b-like nucleotidyl
transferase domain (Aravind and Koonin, 1999). Apart from
canonical poly(A) polymerases (PAPs) that generate poly(A) tail
of mRNA, many noncanonical PAPs have been described from
fission yeast to human (Martin and Keller, 2007; Norbury,
2013). Because some noncanonical PAPs catalyze uridylation
instead of adenylation, noncanonical PAPs are also called termi-
nal uridylyl transferases (TUTases or TUTs). Some PAPs/TUTshave more relaxed nucleotide specificity and carry out both uri-
dylation and adenylation. Humans have seven noncanonical
PAPs/TUTs with distinct substrate specificity and subcellular
localization.
Uridylation of mRNA was initially noticed at the 30 ends of
miRNA-directed cleavage products in Arabidopsis and mamma-
lian cells (Shen and Goodman, 2004). U-tails were also detected
on human replication-dependent histone mRNAs that lack a
poly(A) tail (Mullen and Marzluff, 2008). Histone mRNAs are uri-
dylated and degraded at the end of S phase or upon inhibition
of DNA replication (Mullen andMarzluff, 2008). TUT4 (ZCCHC11)
was reported to catalyze histone mRNA uridylation (Schmidt
et al., 2011; Su et al., 2013), although two other TUTs (TUT1/
MTPAP/PAPD1 and TUT3/PAPD5/TRF4-2) were proposed in
an earlier study (Mullen and Marzluff, 2008). Uridylation induces
rapid decay of histone mRNA through both the 50–30 degradation
by XRN1, DCP2, and LSM1 and the 30–50 degradation by exo-
some and ERI1 (30hExo) (Hoefig et al., 2013; Mullen andMarzluff,
2008; Slevin et al., 2014).
Interestingly, uridylation occurs not only on poly(A)-lacking
mRNAs but also on poly(A)+ mRNAs, as shown first with the actin
(act1) mRNA in fission yeast Schizosaccharomyces pombe
(Rissland et al., 2007).When sixmRNAswere examined by circu-
larized rapid amplification of cDNA ends (cRACE) technique, all
of them were found to bear short U-tails (usually one or two uri-
dines) at the end of poly(A) tails albeit at varying frequencies,
indicating that mRNA uridylation may be widespread in fission
yeast (Rissland and Norbury, 2009). The stability of the urg1
mRNA increased in a mutant lacking Cid1 which is one of the
TUTs in fission yeast (Rissland et al., 2007; Rissland and Nor-
bury, 2009). The uridylation frequency was enhanced in mutants
defective of deadenylase and decapping enzyme (ccr4D and
dcp1-ts). Based on these results, it was proposed that uridyla-
tion and deadenylation may act redundantly to induce decapp-
ing. A more recent study showed that Arabidopsis mRNAs are
also subject to uridylation (Sement et al., 2013). Short uridyl res-
idues (1–2 uridines) were detected on deadenylated, decapped
mRNAs. The Cid1 homolog URT1 is required for uridylation.
But, curiously, URT1 mutation did not have a major impact on
mRNA turnover and instead inhibited trimming of mRNA from
the 30 end (Sement et al., 2013), implying that uridylation may
be necessary to establish the directionality (50–30) rather than
to control the rate of mRNA decay. Therefore, although theseCell 159, 1365–1376, December 4, 2014 ª2014 Elsevier Inc. 1365
observations are intriguing, it was unclear if uridylation has a
conserved function across species and whether animal poly(A)+
mRNAs are also uridylated. In addition, because previous
studies examined a few individual mRNAs by RACE and small-
scale cloning, it remained to be tested whether or not uridylation
occurs globally and if the observed changes in uridylation and
poly(A) length are statistically significant.
To investigate tail structures at the genomic scale, we recently
developed a method called TAIL-seq that deep-sequences the
30 most fragments of RNAs (Chang et al., 2014b). The TAIL-seq
protocol begins with removal of abundant noncoding RNAs
such as rRNA, tRNA, small nuclear RNA (snRNA), and small
nucleolar RNA (snoRNA) by affinity-based depletion and size
fractionation. To avoid any bias against unconventional tails,
TAIL-seq does not use splint ligation or oligo-d(T) enrichment.
The resulting RNA sample enriched with mRNA is subsequently
ligated to the 30 adaptor that contains biotin residues. Following
partial fragmentation, the 30 most fragments are purified using
streptavidin beads and ligated to the 50 adaptor. Paired-end
sequencing of the cDNA library yields 51 nt from the 50 terminus
of the fragment (to identify the transcript) and 231 nt from the 30
terminus (to examine the tail sequences).
TAIL-seq provided us with a unique opportunity to investigate
poly(A) tail length and additional 30 modifications simultaneously
at the genomic scale. Surprisingly, we found that the vast major-
ity of mRNAs are subject to uridylation in mammals. Over 85% of
mRNAs are terminally uridylated at a frequency of higher than
1% in both NIH 3T3 and HeLa cells (Chang et al., 2014b). Inter-
estingly, U-tails are found mainly on mRNAs with short A-tails
(less than25 nt), indicating that uridylation may occur following
deadenylation. We further detected a negative correlation be-
tween uridylation frequency and mRNA half-life, suggesting a
role of uridylation in general mRNA decay.
Current model for eukaryotic mRNA decay pathway is mainly
based on the pioneering genetic and biochemical studies in
Saccharomyces cerevisiae (Garneau et al., 2007; Houseley and
Tollervey, 2009; Norbury, 2013; Parker and Song, 2004). Decay
is generally initiated by deadenylation that is mediated by multi-
ple deadenylases such as the Pan2-Pan3 complex and the Ccr4-
Not complex. Subsequently, deadenylated mRNAs are subject
to either of two major decay pathways. In the 50–30 decay
pathway, the Lsm1–7 complex binds to the 30 end of deadeny-
lated mRNA and recruits the decapping complex (Dcp1/2) that
removes 50 cap structure. Subsequently, 50 monophosphate-
dependent exoribonuclease, Xrn1, digests mRNA processively.
From the opposite orientation, a multisubunit exosome complex
degrades deadenylated mRNAs from the 30 end. This model
seems to apply generally to most, if not all, eukaryotic species.
However, S. cerevisiae is unusual among eukaryotes in that it
does not have any known TUT homolog with uridylation activity
and that mRNAs in S. cerevisiae do not carry terminal U-tails
(Norbury, 2013). Thus, the current model for mRNA decay,
particularly in mammals, may need to be revised to incorporate
the recent findings of pervasive uridylation (Lee et al., 2014).
In this study, we aimed to identify enzyme(s) that catalyze
mRNA uridylation in mammals and understand the significance
of uridylation in the mRNA decay pathway. We discover TUT4
and TUT7 as uridylyl transferases for poly(A)+ mRNAs in humans1366 Cell 159, 1365–1376, December 4, 2014 ª2014 Elsevier Inc.and delineate in detail the action mechanism and molecular
function of uridylation in the mRNA decay pathway. Based on
these results, we propose a revised model for general mRNA
decay in mammals.
RESULT
TUT4 and TUT7 Catalyze mRNA Uridylation
In order to identify enzyme(s) responsible for mRNA uridylation,
we took a candidate approach by depleting seven human
TUTases (Figure S1A available online). Because TUT2 (also
known as GLD2 and PAPD4), TUT4 (ZCCHC11), and TUT7
(ZCCHC6) act redundantly in mono-uridylation of precursor of
let-7 (pre-let-7) (Heo et al., 2012), we knocked down TUTases
in two subgroups (TUT1/3/5/6 and TUT2/4/7) by transfecting
siRNA mixtures into HeLa cells (Figure S1B) and carried out
TAIL-seq (Figure 1A). Overall frequency of uridylation was quan-
tified by dividing the read number of terminally uridylatedmRNAs
by that of total mRNAs. Because short A-tails are preferentially
uridylated (Chang et al., 2014b), uridylation frequency in short
A-tail range (5–25 nt) is shown in Figure 1. Interestingly, when
TUT2/4/7 were depleted, terminal uridylation was significantly
reduced while RNAi of TUT1/3/5/6 did not affect uridylation.
To narrow down on individual TUTases, we generated
knockout HeLa cell lines using TALENs (transcription activator-
like effector nucleases) against the genes coding TUT2, TUT4,
or TUT7 proteins (Figure S1C). We observed a modest decrease
of uridylation in both TUT4 and TUT7 knockout cells, but not in
TUT2 knockout cells (Figure 1B). Repeated attempts to generate
double knockout of TUT4 and TUT7 by utilizing the TALEN and
CRISPR/Cas9 (clustered regularly interspaced short palindromic
repeats/CRISPR-associated protein 9) systems have failed (Fig-
ure S1D). Although genomic deletion was effectively introduced
by the nucleases, mutant clones disappeared during clonal se-
lection processes (Figure S1D), which indicates that the com-
bined activity of TUT4 and TUT7 is essential for cell viability.
Of note, previous studies have shown that TUT4 and TUT7 are
highly similar in their domain organization and activity in pre-
miRNA uridylation (Heo et al., 2012; Liu et al., 2014; Thornton
et al., 2012). Thus, TUT4 and TUT7 (TUT4/7) may act redundantly
in mRNA uridylation as well as in pre-miRNA uridylation. To
confirm this notion, we carried out simultaneous transient RNAi
against TUT4/7 by transfecting siRNAs (Figures 1C and S1E).
The TUT4/7 knockdown cells looked largely normal and prolifer-
ated at a modestly reduced rate with a slight increase of
apoptosis after 4 days of siRNA treatment (Figures S1F and
S1G). Under this condition, uridylation of mRNAwas significantly
reduced when both TUT4 and TUT7 are depleted (Figure 1C).
Oligo-uridylation (R2 U) was more sensitive to TUT4/7 knock-
down than mono-uridylation was (3.71-fold and 1.36-fold
decrease, respectively), suggesting that a relatively high level
of TUT4/7 may be required to generate oligo-U-tails on mRNA.
Gene-level analyses revealed that the majority of mRNA spe-
cies (638 out of 746 genes, 85.5%) are decreased in uridylation
following TUT4/7 knockdown (p = 7.69 3 10100, one-tailed
Mann-Whitney U test) (Figure 1D; Table S1). This result strongly
indicates that TUT4/7 uridylate most, if not all, mRNAs. Figure 1E
presents 21 most abundant mRNAs as examples, the majority of
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Figure 1. TUT4 and TUT7 Are Required for
mRNA Uridylation in Human Cells
(A) Uridylation frequency measured by small-
scale TAIL-seq (with Illumina MiSeq) following
RNAi of the indicated genes. Frequency (y axis) is
the fraction of uridylated reads among the total
number of mRNA reads with short poly(A) tail (5–
25 nt). Light blue refers to mono-uridylation (U),
blue indicates di-uridylation (UU), and dark blue
represents R 3 uridines (U R 3). Uridylation
frequency significantly decreased in siTUT2/4/7
(p = 0.0378 for U; 0.0388 for UU; 0.0201 for U R
3 by one-tailed t test). Error bar represents
SEM from two biologically independent replicates
(n = 2).
(B) Uridylation frequency of mRNAs with short
poly(A) tails (5–25 nt) measured by small-scale
TAIL-seq in knockout HeLa cell lines. Uridylation
frequency was reduced modestly in TUT4 and
TUT7 knockout cells (p = 0.109 for U, 0.0273 for
UU, 0.142 for UR 3 of TUT4 KO; p = 0.150 for U,
0.00685 for UU, 0.0713 for UR 3 of TUT7 KO by
one-tailed t test). Error bar represents SEM from
two replicates (n = 2).
(C) Uridylation frequency of mRNAs with short
poly(A) tails (5–25 nt) measured by TAIL-seq
following simultaneous TUT4 and TUT7 knock-
down (siTUT4/7). Uridylation was reduced
when both TUT4 and TUT7 were depleted
(p = 0.0941 for U, 0.00922 for UU, 0.0105 for
U R 3; one-tailed t test). Error bar represents SEM from three biological replicates (n = 3).
(D) Changes in uridylation of individual mRNA species upon TUT4/7 knockdown. ‘‘Average U length per tail’’ (y axis) is the sum of the number of all uridines on
short A-tails (5–25 nt) divided by the total number of reads with short A-tails. Note that unlike ‘‘uridylation frequency,’’ average U length per tail weighs every
uridine in oligo-U-tails. Each dot represents a transcript withR 15 reads in both samples. Uridylation was significantly decreased following TUT4/7 knockdown
(p = 7.69 3 10100, one-tailed Mann-Whitney U test). The full list is shown in Table S1.
(E) Examples of gene-level uridylation changes. Twenty-one most abundant mRNAs (not including ribosomal protein mRNAs and histone mRNAs) are shown in
the order of mRNA abundance.
See also Figure S1.which are reduced in uridylation upon TUT4/7 knockdown.
Two biological replicate experiments showed a comparable
decrease of uridylation (Figure S1H).
Histone mRNAs that lack poly(A) tails are also uridylated and
their uridylation is dependent modestly on TUT4/7, but not on
TUT1/2/3/5/6 (data not shown). However, poly(A)– histone
mRNAs were excluded from our current data analyses because
we used nonsynchronous cell population for our experiments,
and it is known that uridylation of histone mRNA occurs specif-
ically at the end of S phase (Mullen and Marzluff, 2008; Schmidt
et al., 2011; Su et al., 2013). It would be more appropriate to
investigate histone mRNAs using synchronous cells in future
studies.
TUT4/7 Selectively Oligo-Uridylate mRNAs with Short
A-Tails In Vivo and In Vitro
It is intriguing that uridylation occurs preferentially on shortened
A-tails in plants and animals (Chang et al., 2014b; Sement et al.,
2013). Figure 2A shows the distribution of U-tails over different
lengths of A-tails in HeLa cells. The frequency of uridylation on
the transcripts with a short A-tails (5–25 nt) is higher than that
on the rest (A-tails of >25 nt), especially when only oligo-U
(R2 U) is counted. Note that mRNAs with A-tails of shorter
than 5 nt were excluded from this analysis as it is sometimes diffi-cult to distinguish them from genomic A-rich sequences in 30
UTR. When TUT4/7 were depleted, uridylation on short A-tails
was selectively reduced (especially for oligo-U), indicating that
TUT4/7 are responsible for the specific uridylation of short A-tails
(Figure 2A).
To understand the mechanism underlying such strong associ-
ation with A-tail length, we performed in vitro uridylation assays
using immunopurified full-length TUTases (Figures 2B and S2A–
S2C). Substrate RNAs were chemically synthesized to contain
heterogenous sequences (the last 20 nt from the SHOC2 30
UTR) linked to A-tails of various lengths (0, 10, 25, and 50 nt) at
the 30 end (Figure 2B). We also used a ‘‘swapped’’ control
(A25R) that has a 25 nt A segment at the 50 side of the SHOC2
30 UTR such that the RNA is identical to SHOC2-A25 (A25) in
the overall length and base composition, but lacks an A-tail at
the 30 end (Figure 2B).
Interestingly, RNAs with no tail (A0) or a short A-tail (A10) were
oligo-uridylated efficiently by TUT4 under the condition where
pre-let-7a-1 is mono-uridylated weakly (Figure 2B). A25 and
A50 were less efficiently uridylated than A0 and A10 were. The
A25R RNA was a much better substrate than the A25 was, indi-
cating that it is the 30 A-tail length (not the overall RNA length) that
is measured by TUT4 (Figure 2B). Comparable results were ob-
tainedwith full-length TUT7 protein (Figures S2A and S2B), againCell 159, 1365–1376, December 4, 2014 ª2014 Elsevier Inc. 1367
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Figure 2. Short A-Tails Are Selectively Uridylated by TUT4 and TUT7
(A) Distribution ofmono-uridylation (top) and oligo-uridylation (bottom) according to the length of poly(A) tails. Poly(A) tail lengths from 5 nt to 231 nt are pooled into
equal-width bins in the logarithmic scale (base 2) (x axis). The left edges (inclusive) of bins are 5, 7, 9, 12, 15, 21, 28, 38, 50, 67, 89, 119, 159, and 212 nt. Uridylation
frequency (y axis) indicates the percentage of uridylated reads within each poly(A) tail size range. Error bar represents SEM (n = 3).
(B) Top: illustration of chemically synthesized RNA substrates. Grey bars represent the last 20 nt of SHOC2 30 UTR and ‘‘A’’ indicates an adenosine. Bottom:
in vitro uridylation assay using immunopurified FLAG-TUT4. RNA (0.45 nM) was used in each reaction. The products were resolved on 6% polyacrylamide
sequencing gel containing 7 M urea. The average length of uridylation is shown below each band. See Extended Experimental Procedures for quantification
method.
(C) Top: illustration of chemically synthesized RNA substrates. Green bars represent the last 20 nt of CALM1 30 UTR and ‘‘A’’ indicates an adenosine. Bottom:
in vitro uridylation assay using recombinant TUT7 C-terminal fragment (951–1,495 aa) purified from E. coli. RNA (0.45 nM) and 14 nM of recombinant TUT7 were
used in each reaction. Extension products were resolved on 6% polyacrylamide sequencing gel containing 7 M urea. The average length of uridylation was
quantified as in (B).
See also Figure S2.
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Figure 3. PABP Inhibits Uridylation of Polyadenylated mRNA
In vitro uridylation assay by using recombinant TUT7 (951–1,495 aa) with a
varying concentration of recombinant PABPC1 (0, 10, or 40 nM). 0.45 nM of
RNA and 160 nM of recombinant TUT7 (rTUT7) were used in the reaction.
Extension products were resolved on 6% polyacrylamide sequencing gel
containing 7 M urea. The average length of uridylation was quantified as
described in Extended Experimental Procedures and shown below each band.
See also Figure S3.demonstrating that these two related enzymes are functional pa-
ralogs. The U-tail length in Figures S2A and S2B was overall
shorter than those in Figure 2B because the amount of immuno-
precipitated TUT7 was smaller than that of TUT4 in Figure 2B
(data not shown).
We also prepared recombinant TUT7 protein (951–1,495 aa)
from Escherichia coli and used the fragment for in vitro uridyla-
tion assay (Figure S2C). Apart from the SHOC2 RNAs (Fig-
ure S2D), we synthesized and tested another series of RNAs
based on theCALM1 30 UTR sequences (Figure 2C). The purified
protein fragment was fully capable of carrying out uridylation in
an A-tail length-dependent manner with both RNAs (Figures
2C and S2D, see below). Thus, the C-terminal half of TUT7 is suf-
ficient to recognize and uridylate single-stranded RNAs with a
short A-tails (less than 25 nt), in a 30 UTR sequence-indepen-
dent manner. These results suggest that TUT4/7 possess an
intrinsic ability to measure the 30 terminal A length and avoid
uridylation of long A-tails.
PABP Suppresses Uridylation of Poly(A)+ mRNA
As poly(A)+ mRNAs are associated with poly(A) binding protein
(PABP) in cells, we asked if PABP has an influence on mRNA
uridylation. It was previously shown that PABP preferentially in-
teracts with poly(A) or A-rich sequences (Eliseeva et al., 2013).
The binding affinity increases as the A stretch gets longer (Eli-
seeva et al., 2013; Khanam et al., 2006; Ku¨hn and Pieler, 1996;
Sachs et al., 1987). Full-length PABP occupies an 25 nt A-tailas determined by nuclease digestion assay (Baer and Kornberg,
1983; Eliseeva et al., 2013). In order to test an effect of PABP on
uridylation, we carried out in vitro uridylation assays in the pres-
ence of recombinant PABPC1 (Figure 3). When PABPC1 was
added to RNA, uridylation of RNAs with long poly(A) tail (A25
and A50) was suppressed even at a low concentration of
PABPC1 (10 nM) while those with no or short A-tail (A0, A10,
and A25R) remained largely unaffected (Figure 3). This result
suggests that PABPC1 binds preferentially to long poly(A) tails
and protects them from TUT4/7 and thereby enhances the selec-
tivity of uridylation according to poly(A) tail length.
Taken together, our results suggest that the strict dependence
on the A-tail length observed in vivo may be determined by the
combination of two factors: (1) the intrinsic ability of TUT4/7 to
measure poly(A) stretch (Figure 2), and (2) the protective activity
of PABP (Figure 3).
As deadenylation is thought to occur mainly in the cytoplasm,
we examined the localization of TUT4/7 by western blotting. The
TUT4 and TUT7 proteins are mainly localized in the cytoplasm
(Figure S3). Thus, TUT4/7 may function mainly in the metabolism
of cytoplasmic, deadenylated mRNAs.
Uridylation Facilitates Global mRNA Decay
To understand the functional consequences of uridylation, we
measured mRNA half-life in HeLa cells with or without TUT4/7
knockdown (Figure 4A). mRNA levels were determined by
RNA-seq at 0, 1, 2, and 4 hr after actinomycin D treatment that
blocks transcription. To avoid any bias from tail length variation,
we omitted the oligo-dT enrichment step and instead used Ribo-
Zero to remove abundant rRNAs prior to cDNA library construc-
tion. We couldmeasure turnover rates of 1,829mRNAs. In TUT4/
7-depleted cells, the majority of mRNAs (1,426 out of 1,829
[78.0%]) showed increase stability (Figure 4A, left panel; Table
S2). Half-lives were increased by30% on average, andmedian
half-life was extended from 9.45 hr to 11.2 hr (Figure 4A, right
panel).
Of note, although TUT4/7 contribute to let-7 biogenesis, dou-
ble knockdown of TUT4/7 (without simultaneous knockdown of
TUT2) did not substantially affect the let-7 level (Heo et al.,
2012). In fact, our transcriptome analyses show that mRNAs
are globally upregulated, indicating that the changes in mRNA
half-life observed in this study cannot be attributed to specific
regulation of let-7 biogenesis.
For validation of the impact of TUT4/7 depletion onmRNA sta-
bility, five mRNAs (SHOC2, TRIM24, RB1CC1, MET, and XRN1)
were measured by quantitative RT-PCR after actinomycin D
treatment (Figure 4B). None of these mRNAs contains a let-7
binding site with seed match in their 30 UTR, yet all of them
showed increased stability when TUT4/7 were depleted. There-
fore, our results demonstrate that TUT4/7 play an important role
in bulk mRNA degradation in a let-7 independent manner.
Next, to examine the effect of overexpressed TUTase on
mRNA expression, we carried out tethering experiments in
HeLa cells (Figure 4C, left panel). A related experiment was re-
ported recently in Xenopus oocytes: when Xenopus TUT7 homo-
log was tethered to the 30 UTR of luciferase reporter mRNA,
luciferase activity was reduced without significant changes in
mRNA, implicating translational repression (Lapointe andCell 159, 1365–1376, December 4, 2014 ª2014 Elsevier Inc. 1369
A Measurement of mRNA half-life by RNA-seq
B Measurement of mRNA half-life by qRT-PCR
C Tethering experiment
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Figure 4. Uridylation Promotes mRNA Degradation
(A) Transcriptome-wide change of mRNA half-life determined by RNA-seq. Left: experimental scheme. HeLa cells were transfected twice and harvested at 0, 1, 2,
and 4 hr following actinomycin D treatment. Center: changes of average mRNA half-life upon TUT4/7 knockdown from two biological replicates. The range of
display is limited to between 0 and 30 hr for the better visual recognition (232 out of 1,829mRNAs are outside of the view). The full list is available in Table S2. Right:
distribution of mRNA half-lives in control or TUT4/7 knockdown cells. A box represents the first and third quartiles and an internal bar indicates median. Whiskers
span between the ninth and the 91st percentiles. Half-lives of mRNAs are significantly extended by TUT4/7 knockdown (***p = 4.06 3 10155, one-tailed paired
Mann-Whitney U test). See Extended Experimental Procedures for the detailed description of procedure.
(legend continued on next page)
1370 Cell 159, 1365–1376, December 4, 2014 ª2014 Elsevier Inc.
Wickens, 2013). However, because mRNA decay activity is
generally suppressed in oocytes (Barckmann and Simonelig,
2013), it was unclear if the observation from frog oocytes can
be generalized. For tethering experiments, we generated con-
structs that express proteins tagged with the lN peptide that in-
teracts with its specific binding sites (BoxB sites) in the 30 UTR of
luciferase mRNA (Figures 4C and S4). Expression of lN protein
modestly increased luciferase expression nonspecifically for an
unknown reason (Figure 4C, middle panel). Nevertheless, teth-
ering of AGO2 repressed luciferase reporter expression (Fig-
ure 4C), as previously shown (Pillai et al., 2004), indicating that
this is a valid system to test the effect of RNA silencing factors.
Neither the negative control TUT2 nor its mutant repressed lucif-
erase reporter expression. But when wild-type TUT4 was teth-
ered to the reporter mRNA, luciferase activity was decreased
to 60% while such reduction was not observed with the cata-
lytically dead point mutant (D1011A) of TUT4 (Figure 4C, middle
panel), indicating that TUT4 suppressed gene expression via ur-
idylation. Quantitative RT-PCR further showed that tethering of
TUT4 induced a reduction of mRNA (Figure 4C, right panel).
Thus, our results collectively indicate that TUT4/7 function as
suppressors of gene expression through mRNA destabilization.
Uridylation Is Involved inmiRNA-InducedGeneSilencing
Our model predicts that if a gene-specific inducer of deadenyla-
tion is introduced into cells, uridylation of the given transcript will
take place, which in turn will facilitate RNA decay. To test our
model, we examined the effect of miRNA as an example, which
is well established to induce specific deadenylation of its com-
plementary targets (Ameres and Zamore, 2013; Djuranovic
et al., 2011; Huntzinger and Izaurralde, 2011; Krol et al., 2010).
We first analyzed the TAIL-seq data from our previous exper-
iment where miR-1 mimic was transfected into HeLa cells
(Chang et al., 2014b). As expected, miR-1 targets undergo dead-
enylation and subsequent downregulation following miR-1
mimic transfection (Figure 5A, middle and lower panels, respec-
tively). Importantly, we detected a specific increase of uridylation
on miR-1 targets whereas the rest of genes stayed largely unaf-
fected (Figure 5A, upper panel). This result is consistent with our
model that deadenylation leads to uridylation.
We next measured turnover rates of miR-1 targets with or
without TUT4/7 knockdown. The mRNAs tested (PTMA, ADAR,
and PGM2) are normally stable (half-lives >24 hr) in cells that
do not contain miR-1 (Figure 5B, black line). When miR-1 was
introduced, their half-lives were shortened to 6.5, 10.0, and
9.4 hr, respectively (Figure 5B, blue line). Upon TUT4/7 deple-
tion, the miR-1 target mRNAs were stabilized (with extended
half-lives of 14.0, 36.1, and 18.1 hr, respectively) (Figure 5B,
red line). Therefore, TUT4/7 are necessary for the facilitated(B) Measurement of mRNA half-life by qRT-PCR. Left: the experimental scheme. R
axis) of five selected genes weremeasured. For normalization,GAPDHmRNAwas
change noticeably by TUT4/7 depletion. Error bar represents SEM (n = 3). Half-
function.
(C) Left: schematic representation of reporter assay system with the lN tetherin
Renilla luciferase activity (n = 3). Right: reporter mRNA levels were determined by q
significantly reduced when AGO2 or TUT4 were tethered (*p < 0.01, **p < 0.001;
See also Figure S4.decay of miRNA targets. We propose that other factors that
cause deadenylation may also induce uridylation and decay,
as shown here with an example of miR-1.
mRNA Decay Factors Remove Uridylated mRNAs
To understand downstream events of uridylation, we disrupted
50–30 or 30–50 exonucleolytic decay factors and examined the
mRNA terminome (Figure S5A). The popsicle-shaped bars in Fig-
ure 6 display the relative quantity of reads with a U-tail (thick
stem) or without a U-tail (thin stem). As U-tail frequencies vary
depending on poly(A) tail length, different A-tail ranges are
shown separately along the horizontal axis. For more informa-
tion, the overall uridylation frequency and poly(A) length distribu-
tion are presented in Figures S5B and S5C, respectively.
In order to inhibit 50–30 decay, we initially depleted amajor 50–30
exoribonuclease XRN1. Interestingly, interference of XRN1 re-
sulted in a strong accumulation of uridylated mRNAs with short
A-tails (%25 nt) (Figure 6A). Additionally, when we depleted
LSM1 (a component of the LSM1-7 complex that is known to
facilitate decapping) or overexpressed dominant-negative mu-
tants of the decapping complex (DCP1 and DCP2) (Chang
et al., 2014a), we detected an increase of uridylation among
short A-tailed mRNAs (%25 nt) (Figure 6B). Short A-tailed
mRNAs increased in abundance (particularly, in the 5–15 nt
range) when the 50–30 decay was suppressed. Note that the level
of uridylated mRNA was upregulated substantially (U1–U3+), ac-
counting for the overall increase of mRNA reads in this range,
while mRNAs without a U-tail did not change significantly (U0).
This result is consistent with a model that deadenylated, uridy-
lated mRNAs are normally degraded rapidly by the 50–30 decay
factors while poly(A)+ mRNAs without U-tails are relatively sta-
ble. The LSM1–7 complex is known to preferentially bind to
RNAs with 30 terminal uridyl residues (Chowdhury et al., 2007;
Sharif and Conti, 2013; Song and Kiledjian, 2007; Zhou et al.,
2014) and facilitate decapping through PATL1 (Pat1p in yeast)
(Marnef and Standart, 2010; Wilusz and Wilusz, 2013). Thus, a
short U-tail may first be recognized by the LSM1–7 complex
which in turn facilitates decapping (by the DCP1/2 complex)
and subsequent 50–30 degradation (by XRN1).
We also investigated the contribution of the 30–50 decay
pathway by depleting 30 exonucleolytic factors. When we
knocked-down RRP41, a core subunit of human exosome, we
detected a substantial accumulation of uridylated mRNAs with
short A-tails (Figure 6C). Combinatorial knockdown of RRP41
and XRN1 resulted in a more pronounced increase of uridylation
(Figure 6C). Therefore, both decay pathways (50–30 and 30–50)
may act at the downstream of uridylation. We also tested a
30–50 exonuclease DIS3L2 which is related to DIS3 and DIS3L.
While DIS3 and DIS3L function as components of exosome,ight: following 0, 2, and 4 hr of actinomycin D treatment, relative abundance (y
used because it was highly stable (half-life > 24 hr, data not shown) and did not
lives are calculated by linear fitting of the log-transformed exponential decay
g. Center: reporter (firefly) luciferase activity was measured and normalized to
RT-PCR (n = 4). Error bars represent SEM. Luciferase activity or RNA level were
two-tailed t test).
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A Changes in uridylation after miR-1 transfection
B Measurement of half-life of miR-1 targets by qRT-PCR
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Figure 5. Uridylation Facilitates miRNA-
Mediated mRNA Decay
(A) Changes in uridylation after miR-1 transfection.
Left: experimental scheme.miR-1 was transfected
into HeLa cells and the cells were harvested after
the indicated time for TAIL-seq. Targets are the
transcripts withR1 miR-1 30 UTR site and down-
regulated by R30% on 12 hr posttransfection of
miR-1 (Guo et al., 2010). Right top: average U
length change relative to 0 hr is shown in each time
point. Average U length per tail is the number of
uridines on short A-tails (5–25 nt) divided by the
total number of reads with short A-tails. Box rep-
resents the interval between the first and third
quartiles, and the internal bar indicates the me-
dian. Whiskers span between the ninth and 91st
percentiles. Average U length of miR-1 target is
significantly extended after miR-1 transfection
(*p = 0.0152, **p = 0.00318, ***p = 5.79 3 104;
one-tailed Mann-Whitney U test). Right middle:
poly(A) tail length change relative to 0 hr. The
length change is represented by log2 odds ratio
between long tails (>25 nt) and short tails (%25 nt)
in one among 3, 6, or 9 hr and 0 hr. A negative value
(<0) indicates increase of the fraction of short tails
compared to 0 hr. Error bars indicate SD among
mRNAs. The portion of short poly(A) tails
expanded more for miR-1 targets than the others
(p = 1.803 106 for 3 hr, p = 8.473 1013 for 6 hr,
p = 1.483 1011 for 9 hr; one-tailedMann-Whitney
U test). Right bottom: mRNA abundance (poly(A)+
tag counts) change relative to 0 hr. Error bars
indicate SD among mRNAs. Expression levels of
miR-1 targets were decreased more than the rest
transcripts (p = 2.09 3 104 for 3 hr, p = 2.65 3
1014 for 6 hr, p = 5.463 1018 for 9 hr; one-tailed
Mann-Whitney U test).
(B) Measurement of half-life of miR-1 targets by
qRT-PCR. Left: the experimental scheme.
Following siRNA transfection for 62 hr, HeLa cells
were transfected with miR-1 or mock transfected.
After 4 hr, actinomycin D was treated and cells
were harvested at 0, 1, 2, and 4 hr. Right: relative
abundance (y axis) of miR-1 target mRNAs were measured. For the normalization, highly stableGAPDHmRNA was used because it did not change significantly
by siTUT4/7 or miR-1 transfection. Error bar represents SEM (n = 3). Half-lives are determined by linear fitting of the log-transformed exponential decay function.DIS3L2 is known to work independently from exosome (Lubas
et al., 2013; Malecki et al., 2013). It was recently shown that
DIS3L2 preferentially binds to long U-tails of pre-let-7 and is
involved in turnover of pre-let-7 and some mRNAs in yeast and
human (Chang et al., 2013; Faehnle et al., 2014; Lubas et al.,
2013; Malecki et al., 2013; Ustianenko et al., 2013). Our TAIL-
seq experiment shows that DIS3L2 depletion results in a modest
accumulation of uridylated reads (Figure 6C). Thus, although we
cannot rule out the possibility of indirect effects, our results sug-
gest thatmultiple decay pathwaysmay participate in the removal
of uridylated mRNAs. Due to the technical limitation of knock-
down experiment, it is currently unclear which pathway plays a
dominant role.
Interestingly, mRNAs with an oligo-U-tail (U2 and U3+) re-
sponded more sensitively to the suppression of decay factors
than those with a mono-U-tail (U1), suggesting that oligo-uridy-
lated mRNAs are more rapidly degraded than mono-uridylated
mRNAs (Figures 6A–6C). Taken together, we propose that1372 Cell 159, 1365–1376, December 4, 2014 ª2014 Elsevier Inc.oligo-uridylated mRNAs are subject to degradation by multiple
factors, and an oligo-U-tail may serve as a decay mark for
nonfunctional, deadenylated mRNAs.
DISCUSSION
In conclusion, this study reveals an integral and general role of
oligo-uridylation in mammalian mRNA decay (model shown in
Figure 7). Upon deadenylation, mRNAs (with A-tails shorter
than 25 nt) lose PABP and instead gain a U-tail by the redun-
dant action of TUT4 and TUT7. The oligo-U-tail triggers decay
by serving as a mark that is recognized by downstream decay
factors. Thus, TUT4/7 function as the ‘‘writers’’ of the decay
mark. It will be interesting in the future to identify the ‘‘readers’’
of the oligo-U-tail and to ask if this modification can be reversed
by ‘‘erasers.’’ The LSM1–7 complex and DIS3L2 are likely candi-
dates that recognize the oligo-Umarks, but further investigations
will be necessary to understand which factor(s) recognize the
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Figure 6. The 50 and 30 mRNA Decay Factors Degrade Uridylated mRNAs
(A–C) Changes of poly(A) tail and uridylation upon knockdown of decay factor(s) detected by small-scale TAIL-seq (with Illumina MiSeq). Fraction of mRNA reads
out of the total poly(A)+ mRNA reads is shown in each poly(A) tail size range. Narrow bars represent reads without U-tails (U0) and wider bars indicate uridylated
reads (U1–U3+). The ‘‘DCP1/2 mut’’ sample derived from cells coexpressed of dominant-negative mutants of DCP1 and DCP2 (DCP1a-GSSG and DCP2-E148Q,
respectively).
See also Figure S5.oligo-U-tails mainly, whether there is any additional factor(s) that
binds to the oligo-U-tails, and what is the molecular basis of the
specific recognition (Lee et al., 2014).
It is intriguing that TUT4/7 are capable of measuring poly(A)
length (Figure 2). Poly(A) tail is unlikely to form a certain structure
through base-pairing, so we do not yet understand how RNA
with a poly(A) tail is discriminated by TUT4/7. It would be inter-
esting to carry out structural studies on TUT4/7 and RNA with
an A-tail of various length. Furthermore, we found that PABPC1
preferentially protects long poly(A) tails from uridylation (Fig-
ure 3). This specific inhibitory effect may come from the length-
dependent binding of PABPC1 (Ku¨hn and Pieler, 1996; Sachs
et al., 1987). Thus, the combined action of TUT4/7 and PABP
may selectively mark nonfunctional mRNAs while translationally
active polyadenylated mRNAs are refractory to uridylation.
Consequently, TUT4/7-mediated uridylation may provide the
molecular basis for the tight control of mRNA stability according
to poly(A) tail length.
We observed that oligo-uridylated mRNAs (with R2 uridines)
are more sensitive than mono-uridylated mRNAs to the knock-
down of TUT4/7 and decay factors. Moreover, oligo-U-tails are
found in a narrow range of short A-tail length while mono-U-tails
are more loosely distributed and found in polyadenylatedmRNAs as well to some extent (Chang et al., 2014b). Thus,
mono-uridylation appears to be less specific than oligo-uridyla-
tion and may be catalyzed in part by a TUT(s) other than TUT4/7.
Furthermore, mono-U-tails may be too short to recruit decay fac-
tors effectively. Oligo-uridylated mRNAs are detected more
frequently after depletion of decay factors, indicating that they
are less stable than mono-uridylated mRNAs in control cells.
Therefore, oligo-U-tails are likely to have a stronger effect in
decay than mono-U-tails do. In fission yeast and plants, it is
currently unclear if there is such a distinction between oligo-
U-tails and mono-U-tails because only a small number of reads
from cloning has been analyzed thus far.
Our transcriptome-wide analyses allowed us to propose a
general model for the decay of poly(A)+ mRNAs. In addition,
given that poly(A) histone mRNA was also proposed to be uri-
dylated by TUT4 (Schmidt et al., 2011; Su et al., 2013), it is
possible that both poly(A)+ mRNAs and poly(A) mRNAs are
degraded by the same general principle involving uridylation
although there may be some differences in details such as the
choice of downstream decay factors. In fact, we detected uridy-
lation on histone mRNAs and on trimmed decay intermediates
lacking poly(A) tail and these U-tails were also dependent on
TUT4/7 (data not shown).Cell 159, 1365–1376, December 4, 2014 ª2014 Elsevier Inc. 1373
Figure 7. Model for Uridylation-Dependent mRNA Decay in Humans
mRNA decay is generally initiated by deadenylation. PABP proteins are
dissociated from mRNA as poly(A) tail becomes shorter (less than 25 nt).
TUT4 and TUT7 act redundantly to uridylate mRNAs with a short A-tail. The
U-tail is in turn recognized by the downstream decay factors (uridylation-
dependent mRNA decay pathway). The LSM1–7 complex binds to the U-tail
and facilitates decapping by the DCP1/2 complex. Decapped mRNAs are
degraded by the 50–30 exonuclease XRN1. Alternatively, the U-tail is recog-
nized by exosome or DIS3L2 that degrade mRNA exonucleolytically from the
30 end. It is currently unclear if and what fraction of deadenylated mRNAs are
degraded through uridylation-independent alternative pathways (indicated
with gray dashed lines).In addition, we found that miR-1 transfection results in an
increased uridylation and facilitated decay of its targets (Fig-
ure 5). These results suggest that uridylation contributes to
miRNA-mediated gene silencing by removing the body of dead-
enylatedmRNAs. Uridylationmay be involved in other decay and
surveillance pathways in mammals, playing a general role. It is
noted that we cannot currently assess if and to what extent uri-
dylation-independent alternative pathway(s) contribute to bulk
mRNA decay.
TailingofmRNA is found inmanyeukaryotes,withsomenotable
differences among the species. In filamentous fungus Aspergillus
nidulans, mRNAs carry 30 tails mixed with cytidine and uridine
(Morozovet al., 2010). In adoubledeletionmutantofnoncanonical
PAPs, CutA and CutB, this ‘‘CUCU’’ modification was abrogated,
and transcripts were stabilized, indicating that a CUCU tail also
serves as a decay mark despite the difference in base composi-
tion (Morozovetal., 2010, 2012). Inplants, althoughuridylationoc-
curs similarly to mammals, mRNA half-life did not change in the
urt1mutants, and the reason underlying the difference is currently
unclear (Sementet al., 2013).Another variationamong the species
is that uridylation occurs selectively on deadenylated mRNAs in
mammals and plants whereas uridylation appears to be indepen-
dent of poly(A) tail length in S. pombe and A. nidulans (Morozov
et al., 2010; Rissland and Norbury, 2009). Deadenylation may
not be a prerequisite for uridylation in fungi as they possess
shorter poly(A) tail (20–30 nt in median) than mammals (60–
100 nt in median) and plants (50–60 nt in median) (Chang et al.,
2014b; Morozov et al., 2010; Subtelny et al., 2014). Thus, further1374 Cell 159, 1365–1376, December 4, 2014 ª2014 Elsevier Inc.investigations are clearly necessary to delineate the commonal-
ities and differences of uridylation in diverse systems.
Tailing-mediated decay is deeply conserved and found even in
prokaryoteswheremRNAs typically endwith stem loop structure
and are degraded in an adenylation-dependent manner (Be-
lasco, 2010; Houseley et al., 2006). An oligo-A-tail serves as a
single-stranded toehold for 30 exonucleases that are otherwise
hindered by the terminal stem loop. A related phenomenon
was observed in budding yeast where noncanonical PAPs, Trf4
and Trf5, adenylate defective nuclear RNAs and facilitate their
degradation by exosome (Houseley et al., 2006; Norbury,
2013). Our current work shows that mammalian cytoplasmic
mRNAs use uridylation, instead of adenylation, to promote
mRNA decay. Together with previous findings (Morozov et al.,
2010; Mullen and Marzluff, 2008; Rissland and Norbury, 2009),
our study establishes a fundamental and conserved role for
tailing in the mRNA decay pathways.
EXPERIMENTAL PROCEDURES
Construction of TAIL-Seq Library
TAIL-seqwas carried out as described previously (Chang et al., 2014b). Briefly,
25–50 mg of total RNA was extracted using TRIzol (Invitrogen), purified with
RNeasy MinElute column (QIAGEN), and rRNA-depleted by using Ribo-Zero
kit (Epicentre). The RNAs were ligated to the biotinylated 30 adaptor and
partially digested by RNase T1 (Ambion). The fragmented RNAs were precip-
itated with streptavidin beads, phosphorylated at the 50 end, and gel purified
(500–1,000 nt). The purified RNAs were ligated to the 50 adaptor, reverse-
transcribed, and amplified by PCR. The cDNA libraries were mixed with PhiX
control library v3 (Illumina) and spike-in mixture and then sequenced by
paired-end run (51 3 251 cycles) on Illumina MiSeq (small-scale TAIL-seq)
or HiSeq 2500. Resulting data were processed as previously described (Chang
et al., 2014b). See also Extended Experimental Procedures.
In Vitro Uridylation Assay
For immunoprecipitation of FLAG-TUTases, HEK293T cells grown on
10 cm dishes were collected 48 hr after transfection with FLAG-TUTase
expression plasmids (full-length human TUT4 [1–1,640 aa] and human
TUT7 [1–1,495 aa]). The cells were incubated in ice-cold Buffer D (200 mM
KCl, 10 mM Tris-HCl [pH 8.0], 0.2 mM EDTA) for 20 min followed by sonicat-
ion on ice and centrifugation twice for 15 min at 4C. The supernatant was
incubated with 5 ml of anti-FLAG antibody-conjugated agarose beads (anti-
FLAG M2 affinity gel, Sigma) with constant rotation for 1 hr at 4C. The beads
were washed six times with Buffer D. Uridylation reaction was done in a total
volume of 30 ml in 3.2 mM MgCl2, 1 mM DTT, 0.67 U/ml RNase inhibitor
(Promega, N2515), 0.25 mM UTP, 0.45 nM of 50 end-labeled RNA, and
15 ml of immunopurified proteins on beads or 3X Flag-peptide (Sigma) eluted
proteins in Buffer D. When uridylation assay was done with recombinant
TUT7 (951–1,495 aa), 14 nM of protein was used. The reaction mixture was
incubated at 37C for up to 10 min. For uridylation assay in the presence
of PABPC1, 10–40 nM of recombinant human PABPC1 (Origene,
TP307354) was preincubated with RNA for 10 min and then uridylation was
carried out by adding 160 nM of recombinant TUT7 (951–1,495 aa). Buffer
D with final 300 mM KCl was used when uridylation assay was carried out
in the presence of PABPC1. The RNA was purified from the reaction mixture
by phenol extraction and run on 6% polyacrylamide sequencing gel with 7 M
urea (20 3 40 cm, 0.4 mm thick) at constant 1,500 V for 2 hr. The gel was
exposed to phosphor imaging plate (Fujifilm) and read by Typhoon FLA
7000 (GE Healthcare). The signal intensity profile was quantified using
MultiGauge v3.0 (Fujifilm). In Figure S2D, 12.5% polyacrylamide gel was
used. The SHOC2 30 UTR and CALM1 30 UTR were selected as RNA sub-
strates as they do not contain homopolymeric adenosines at the 30 end.
RNAs were synthesized by ST Pharm.
The list of RNA oligos is shown in Table S3.
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